NCT05997719Recruiting
Exploring Cancer Evolution, Prognostic and Predictive Biomarkers in EGFR-mutant NSCLC
Source: ClinicalTrials.gov · Last updated 24 Oct 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To investigate genomic architecture, cancer evolution and their relationship with clinical outcomes in EGFR-mutant NSCLC.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 3 Aug 2023
- Start date
- 10 Aug 2023
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- Sun Yat-sen University
- Diseases
- Lung cancer
- NCT number
- NCT05997719
What you commit to
- Study type: Observational
- Planned participants: 150
- From 10 Aug 2023 to the primary completion date, 31 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of other malignancies within 5 years (excluding basal cell carcinoma of the skin or other carcinoma in situ that has been resected).
- Subjects with active, unstable systemic diseases, such as active infection, uncontrolled hypertension, heart failure (NYHA class \>= II), unstable angina pectoris, acute coronary syndrome, severe arrythmia, severe liver, kidney or metabolic diseases, HIV infection.
Other
- Unable to provide sufficient tumor tissue for analysis.
- Subjects who are deemed unable to comply with the study requirements or complete the study.
Who the study is looking for
- Aged 18 years or older
- Histologically or cytologically confirmed non-small-cell lung cancer
- ECOG PS=0-2
- EGFR mutations confirmed by tissue or peripheral blood
- Can provide tumor tissue samples (fresh or archived)
- The subject should have good compliance, who would participate in the research voluntarily, and sign the informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sun Yat-sen University Cancer Center Coordinator of this site? Confirm its status | Guanzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.